Haq et al. reported that the activation of BRAF/MAPK pathway in cutaneous melanoma cells decreases MITF, which, in turn, decreases PGC1α (peroxisome proliferator-activated receptor γ coactivator 1), which is a potent activator of oxidative phosphorylation [81]. This evidence concerns the gene BRAF and cutaneous melanoma.